Sands Capital Alternatives, LLC
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 8, 2026), Sands Capital Alternatives, LLC reported 21 stock positions worth $421.2 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 22.3% of the portfolio, followed by Klaviyo Class A (KVYO, 16.9%) and Spyglass Pharma (SGP, 15.4%). Compared with Q4 2025, it opened 1 new position, added to 5 and reduced 1. The biggest buy was a new position in Spyglass Pharma (SGP) and the biggest sale Nu Holdings Ltd./Cayman Isl-A (NU, shares −5%).
- Most Recent 13F
- Q2 2026
- Location
- ARLINGTON, VA
- CIK
- 0001846444
- Portfolio Value
- $421.2M (Q1 2026)
- SEC Filing
- 0001846444-26-000005 ↗ filed May 8, 2026
Holdings Value
Holdings 21 stocks · $421.2M
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 22.30% | 6,537,769 | $93.9M | Reduce -4.7% |
| KVYO Klaviyo Inc. Class A | 16.86% | 3,649,678 | $71.0M | No change |
| SGP Spyglass Pharma Inc. | 15.38% | 2,500,012 | $64.8M | New |
| BBNX Beta Bionics Inc. | 8.82% | 3,708,043 | $37.2M | Add +3.9% |
| IKT Inhibikase Therapeutics Inc. | 5.19% | 13,018,965 | $21.9M | No change |
| CPNG Coupang Inc. | 4.54% | 1,012,091 | $19.1M | Add +16.3% |
| IOT Samsara Inc. Class A | 4.22% | 560,287 | $17.8M | Add +20.2% |
| DASH DoorDash Inc. Class A | 3.97% | 111,231 | $16.7M | Add +16.3% |
| BIOA Bioage Labs Inc. | 3.27% | 786,353 | $13.8M | No change |
| TXG 10X Genomics Inc. Class A | 2.43% | 481,770 | $10.2M | No change |
| DDOG Datadog Inc. Class A | 2.40% | 85,793 | $10.1M | No change |
| ABOS Acumen Pharmaceuticals Inc. | 2.08% | 3,720,105 | $8.8M | Add +8.9% |
| TOST Toast Inc. Class A | 1.90% | 301,647 | $8.0M | No change |
| TARS Tarsus Pharmaceuticals Inc. | 1.42% | 85,000 | $6.0M | No change |
| TTAN Servicetitan Inc. Class A | 1.35% | 89,856 | $5.7M | No change |
| MNDY Monday.com Ltd. | 1.11% | 67,868 | $4.7M | No change |
| TSHA Taysha Gene Therapies Inc. | 0.77% | 724,873 | $3.2M | No change |
| SNOW Snowflake Inc. | 0.73% | 20,253 | $3.1M | No change |
| ACRV Acrivon Therapeutics Inc. | 0.70% | 2,122,605 | $3.0M | No change |
| CADL Candel Therapeutics Inc. | 0.47% | 405,837 | $2.0M | No change |
| FIG Figma Inc. Class A | 0.09% | 18,286 | $387K | No change |
Portfolio Sells Q4 2025 → Q1 2026
| NU Nu Holdings Ltd./Cayman Isl-A | Reduce -4.7% | 22.30% | +0.15 |
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 24 | $613.5M | ALMR, NU, KVYO, BBNX, SGP |
| Q1 2026 | 21 | $421.2M | NU, KVYO, SGP, BBNX, IKT |
| Q4 2025 | 20 | $518.5M | KVYO, NU, BBNX, IKT, DASH |
| Q3 2025 | 20 | $456.4M | NU, KVYO, BBNX, CPNG, DASH |
| Q2 2025 | 19 | $507.8M | KVYO, NU, DASH, BBNX, CPNG |
| Q1 2025 | 20 | $408.9M | KVYO, NU, DASH, BBNX, IKT |
| Q4 2024 | 21 | $459.7M | KVYO, NU, DASH, IKT, CPNG |
| Q3 2024 | 20 | $355.8M | KVYO, NU, DASH, BIOA, ACRV |
| Q2 2024 | 20 | $298.6M | NU, KVYO, DASH, PATH, SNOW |
| Q1 2024 | 20 | $414.7M | NU, KVYO, DASH, PATH, SNOW |